; Single Cell Analysis Market Size, Share, Forecast, 2032

Single Cell Analysis Market

Single Cell Analysis Market Size, Share, and Analysis, By Product (Consumable and Instruments), By Application (Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, and Others), By Cell Type (Human, Animal, and Microbial), and End Users (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospitals and Diagnostic laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032

Published on: Dec-2023
Report Code: FG HC 01772
No. of Pages: 170-350
Report Format: PDF

Single Cell Analysis Market is expected to grow at a CAGR of 15.9% in the forecast period (2023-2032), with the market size valued at USD 3.20 billion in 2021 and projected to reach USD 16.2 billion by 2032, up from USD 3.7 billion in 2022.

Product Overview

Single-cell analysis is the study of cell interactions, genomes, transcriptomics, proteomics, and metabolomics at the single-cell level. Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of growth in the single-cell analysis market. In addition, the market is advancing as a result of the epidemic. Single-cell RNA sequencing is used in cancer research to examine complex tissues at the level of the individual cells, identifying differences in gene expression and tracking the growth of tumors to stop further cellular degeneration.

Source: Fatpos Global

Market Highlights

Single Cell Analysis Market is expected to exhibit a CAGR of 15.9% during the forecast period.

Single Cell Analysis Market is expected to reach USD 16.2 billion, growing at a CAGR of 15.9% owing to the advances in genomics, transcriptomics, and proteomics, which enable researchers to examine biological complexity at the single-cell level. Applications in cancer research, immunology, and neuroscience are key drivers, fuelling demand for technologies such as single-cell RNA sequencing and flow cytometry. Furthermore, the industry benefits from the advancement of customized medicine and drug discovery initiatives.

Source: Fatpos Global

Single Cell Analysis Market Segmentation

Oncology segment to develop rapidly due to the rise in cancer prevalence

Based on Application, the market is divided into oncology, immunology, neurology, stem cell research, non-invasive prenatal diagnosis, in-vitro fertilization, and various others. Oncology segment registered a major share in 2021 due to its increased demand. It is anticipated that this trend will continue in the upcoming years, especially due to the continuing increase in cancer prevalence worldwide. Additionally, the success of single cell analysis in early cancer cell diagnoses has made a substantial contribution to the expansion of the oncology market. The importance of single cell analysis in advancing precision medicine and enhancing results in cancer research and diagnostics is highlighted by this.

Consumables segment consistent demand make it a key revenue driver

By product, the Single Cell Analysis Market is typically segmented into consumables and instruments. Both in terms of market share and compound annual growth rate (CAGR), the consumables segment dominates this market landscape. Due to several factors, this dominance is anticipated to continue during the projection period. The consumables category benefits from high usability, frequent reagent purchases, and a steady demand resulting from the ongoing requirement for assay-related items. Additionally, as target diseases become more prevalent, this increases the demand for consumables in the field of single cell analysis, highlighting its crucial role in advancing cellular research and diagnostics.

Source: Fatpos Global

Market Dynamics

Growth Drivers

Increasing cancer prevalence to drive market growth

Single-cell analysis is critical for discovering biomarkers linked to malignancy. GLOBOCAN predicts that the number of cancer cases would reach 30 million by 2040. Cancer is a very heterogeneous disease with numerous cell types within a tumor. Researchers can use single-cell analysis to deconstruct this heterogeneity and analyze individual cancer cells at the molecular level. Researchers get a full understanding of tumor heterogeneity by examining gene expression, genetic alterations, and other biological features at the single-cell level.

Swift economic expansion to boost market growth

Rapid urbanization, digitization, improved healthcare infrastructure, and rising awareness are all anticipated to support market expansion. Additionally, the expanding interest in customized medicine and the advancement of stem cell research are anticipated to drive market expansion. Furthermore, the market's expansion during the anticipated period is tempered by the growing popularity of single-cell analysis tools.


High cost of single-cell analysis products

Single-cell analysis tools' high price points are a major barrier for poor nations' research institutes and rising markets. Investment in pricey single-cell analysis technology is made more difficult by the fact that these locations frequently have financial constraints, currency fluctuations, and restricted access to resources. Collaborations between research institutes may be hampered by the financial implications of single-cell analysis products. When the necessary equipment and reagents are expensive and not widely available, sharing data and reproducing studies becomes difficult.

Recent Developments

  • CytoFLEX SRT Benchtop Cell Sorter, a next generation device, was introduced in March 2021 by Beckman Coulter Life Sciences. The power of single-cell analysis will be made more accessible to laboratories by showcasing innovative technologies that automate, streamline, and configure sorting and stream management.
  • The BD FACSDiscover S8 Cell Sorter, a brand-new cell sorting instrument with two ground-breaking technologies, was introduced by Becton, Dikinson and Company in May 2023. This cell sorting instrument enables researchers to discover more detailed information about cells that was previously invisible in conventional flow cytometry experiments.

Single Cell Analysis Market

Key Players:

  • Illumina Inc.
  • 10x Genomics Inc.
  • Fluidigm Corporation
  • BD Biosciences
  • Mission Bio
  • NanoString Technologies
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Agilent Technologies
  • Miltenyi Biotec
  • Dolomite Bio (a part of Blacktrace Holdings)
  • Bio-Techne Corporation
  • Zeiss Group
  • Abcam plc
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Single Cell Analysis Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. According to projections, North America will hold the largest market share. The substantial market share held by North America is credited to several causes, including growing partnerships between well-known businesses, technical breakthroughs, and the expansion of the biotechnology and pharmaceutical industries.

Due to factors like expanding opportunities in cancer cell research and rising consumer awareness of medical technology advancements that have increased demand for customized treatment, Europe is predicted to experience moderate market growth. The region of Asia-Pacific is anticipated to expand at the greatest CAGR, mostly as a result of an aging population, growing government initiatives to support life science research, and expanding biotech R&D expenditures. Lower market revenue shares and growth rates are predicted to come from Latin America, the Middle East, and Africa.

 Source: Fatpos Global

Impact of Covid-19 on Single Cell Analysis Market

The COVID-19 outbreak had resulted in the economic downfall. Several countries had imposed lockdowns and applied travel restrictions to control the spread of the virus. Governments around the world increased financing for vaccine development and study as a result of the COVID-19 pandemic, which had a favorable impact on the single cell analysis sector. The demand for single-cell analysis instruments for COVID-19 investigations increased despite difficulties in production and sales brought on by governmental constraints. For proper diagnosis, prognosis, and the development of therapies for severe cases, it is essential to comprehend host immune responses at the single-cell level. Understanding the roles of immune cells through single-cell analysis helps scientists create more potent vaccines and immunotherapies.

Single Cell Analysis Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Single Cell Analysis Market Scope and Segments:



Study Period


Base Year


Forecast Period


Historical Period


Growth Rate

CAGR of 15.9% from 2022-2032


Value (USD Billion)


Main Segments List

By Product

  • Consumables
  • Instruments

By Application

  • Cancer
  • Immunology
  • Neurology
  • Stem cell
  • Non-invasive prenatal diagnosis
  • Others

By Cell Type

  • Human
  • Animal
  • Microbial

By End Users

  • Academic & Research laboratories
  • Biotechnology & Pharmaceutical companies
  • Hospitals and Diagnostic laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions (FAQ):

Single Cell Analysis Market size was values at USD 3.20 billion in 2021 and is projected to reach the value of USD 16.2 billion in 2032, exhibiting a CAGR of 15.9% during the forecast period.

The market for tools and methods used to investigate individual cells at a high resolution is known as the "Single Cell Analysis Market." It is essential for understanding cellular activities and heterogeneity in several disciplines, including genomics, proteomics, and disease research.

The consumable segment and the oncology segment accounted for the largest single cell analysis market share.

Key players in the single cell analysis market include Illumina Inc., 10x Genomics Inc., Fluidigm Corporation, BD Biosciences, Mission Bio, NanoString Technologies, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Agilent Technologies, Miltenyi Biotec, Dolomite Bio, Bio-Techne Corporation, Zeiss Group, Abcam plc, and other prominent players.

Increasing cancer prevalence and swift economic expansion are the factors driving the Single Cell Analysis Market.

Select License Type


Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555

Select License Type


Report accessible by 1 user only

Sample Request

Client Testimonials